1Forbes GB. Glycogen storage disease: report of a case with abnormal glycogen structure in liver and skeletal muscle. J Pediatr, 1953,42 (6):645-653. 被引量：1
3Zimakas PJ, Rodd CJ. Glycogen storage disease type Ⅲ in inuit children. CMAJ, 2005,172(3) :355-358. 被引量：1
4Chen YT, Burchell A. Glycogen storage disease. In: Scriver CR, Beaudet AL, Sly WS, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill,1995:925 -965. 被引量：1
5White RC, Nelson TE. Re-evaluation of the subunit structure and molecular weight of rabbit muscle amylo-1,6-glucosidase-4-alpha- glucanotransferase. Biochem Biophys Acta, 1974,365(1): 274-280. 被引量：1
6Coleman RA, Winter HS, Wolf B, et al. Glycogen debranching enzyme deficiency :long- term study of serum enzyme activities and clinical features. J Inherit Metab Dis, 1992,15(6) :869-881. 被引量：1
7Ingle SA, Moulick ND, Ranadive NU, et al. Hepatocellular failure in glycogen storage disorder type 3. J Assoc Physicians India, 2004,52 : 158-160. 被引量：1
8Haagsma EB, Smit GP, Niezen-Koning KE, et al. Type Ⅲb glycogen storage disease associated with end- stage cirrhosis and hepatocellular carcinoma. The Liver Transplant Group.Hepatology, 1997,25(3) :537-540. 被引量：1
9Lee PJ, Deanfield JE, Burch M, et al. Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type Ⅲ. Am J Cardiol, 1997,79 (6) :834-838. 被引量：1
10Shen JJ, Chen YT. Molecular characterization of glycogen storage disease type Ⅲ. Curr Mol Med,2002,2 (2):167- 175. 被引量：1
二级参考文献7
1Parvari R, Moses S, Shen J, et al. A single-base deletion in the 3'-coding region of glyeogen-debranehing enzyme is prevalent in glycogen storage disease type Ⅲ A in a population of North African Jewish patients. Eur J Hum Genet, 1997,5:266-270. 被引量：1
2Santer R, Kinner M, Steuerwald U, et al. Molecular genetic basis and prevalence of glycogen storage disease type Ⅲ A in the Faroe Islands. Eur J Hum Genet,2001,9:388-391. 被引量：1
3Wolfsdorf JI, Holm IA, Weinstein DA. Glycogen storage diseases.Phenotypic, genetic, and biochemical characteristics, and therapy.Endocrinol Metab Clin North Am , 1999,28:801-823. 被引量：1
4Kiechl S, Kohlendorfer U, Thaler C,et al. Different clinical aspects of debrancher deficiency myopathy. J Neurol Neurosurg Psychiatry ,1999,67:364-368. 被引量：1
5Shaiu WL, Kishnani PS, Shen J, et al. Genotype-phenotype correlation in two frequent mutations and mutation update in type Ⅲ glycogen storage disease. Mol Genet Metab,2000,69:16-23. 被引量：1
6Bao Y, Yang BZ, Dawson TL Jr, et al. Isolation and nucleotide sequence of human liver glycogen debranching enzyme mRNA:identification of multiple tissue-specific isoforms. Gene, 1997,197:389-398. 被引量：1
7Shen J, Liu HM, Bao Y, et al. Polymorphic markers of glycogen debranching enzyme allowing linkage analysis in families with glycogen storage disease type Ⅲ. J Med Genet, 1997,34:34-38. 被引量：1
5Shen JJ, Chen YT. Molecular characterization of glycogen storage disease type Ⅲ. Curr Mol Med,2002,2 : 167-175. 被引量：1
6Scriver CR , Beaudet AL, Sly WS, et al. The metabolic and molecular basic of inherited disease. 8th ed. New York: McGraw- Hill,2001:1521-1551. 被引量：1
7Demo E, Frush D, Gotffried M, et al. Glycogen storage disease type Ⅲ-hepatocellular carcinoma a long-term complication? J Hepatol, 2007,46 : 492-498. 被引量：1
8Momoi T, Sano H, Yamanaka C, et al. Glycogen storage disease type Ⅲ with muscle involvement: reappraisal of phenotypic variability and prognosis. Am Journal Med Genet ,1992 ,42 :696-699. 被引量：1
9Kiechl S, Kohlendorfer U,Thaler C, et al. Different clinical aspects of debrancher deficiency myopathy. J Neurol Neurosury Psychia try, 1999,67:364-368. 被引量：1
10Labrune P, Huguet P, Odievre M. Cardiomyopathy in glycogen- storage disease type Ⅲ: clinical and echographyic study of 18 patients. Pediatr Cardiol, 1991,12 : 161-163. 被引量：1
